Effects of protein-energy malnutrition and human immunodeficiency virus-1 infection on essential fatty acid metabolism in children. NLM AIDSLINE Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Effects of protein-energy malnutrition and human immunodeficiency virus-1 infection on essential fatty acid metabolism in children.

Nutrition. 2000 Jun;16(6):447-53. Unique Identifier : AIDSLINE MED/20329813
Decsi T; Koletzko B; Division of Metabolic Disorders and Nutrition, Department of; Pediatrics, Dr. von Haunersches Kinderspital, Ludwig-Maximilians; University, Munich, Germany.


Abstract: This report summarizes data on the availability of essential fatty acids (EFAs) and their long-chain polyunsaturated fatty acid (LCPUFA) metabolites in protein-energy malnutrition (PEM), in human immunodeficiency virus-1 (HIV-1) infection for which less information is available, and the combination of both PEM and HIV-1. The contribution of different EFAs and LCPUFAs to the fatty-acid composition of plasma and erythrocyte membrane lipids was found to be reduced in children with PEM in comparison with well-nourished children. In addition to limited dietary EFA supply, reduced bioconversion of EFAs to their respective LCPUFA metabolites and/or peroxidative degradation of LCPUFAs may contribute to the reduction of LCPUFA status in malnourished children. Restoration of normal energy, protein, and EFA intakes does not appear to readily correct abnormalities of plasma and erythrocyte membrane LCPUFA values. Enhanced dietary supply of LCPUFAs and/or improved supply of antioxidant vitamins may represent novel therapeutic modalities in severe PEM. With and without PEM, HIV infection was related to altered availability of various EFAs and LCPUFAs in HIV-seropositive children. The plasma total lipid fatty-acid profiles seen in well-nourished children with HIV infection were compatible with an HIV infection-related enhancement of the metabolic activity of the conversion of EFAs to their respective LCPUFA metabolites. However, the plasma phospholipid EFA and LCPUFA profiles seen in severely malnourished children with HIV infection more closely resembled those seen in children with PEM but without HIV infection than in those in children with HIV infection but no PEM. Metabolic studies using stable isotope-labeled fatty acids may contribute to better understanding of the HIV-related changes in EFA metabolism and clearly are needed before therapeutic conclusions can be drawn.
Keywords: JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL alpha-Linolenic Acid/BLOOD Acquired Immunodeficiency Syndrome/*BLOOD/*COMPLICATIONS Arachidonic Acid/BLOOD Child Docosahexaenoic Acids/BLOOD Fatty Acids, Essential/*BLOOD Human Linoleic Acid/BLOOD Lipids/BLOOD Protein-Energy Malnutrition/*BLOOD/*COMPLICATIONS Support, Non-U.S. Gov'tKWDjournalarticlereviewreview,tutorialalpha-linolenicacid/bloodacquiredimmunodeficiencysyndrome/KWDblood/KWDcomplicationsarachidonicacid/bloodchilddocosahexaenoicacids/bloodfattyacids,essential/KWDbloodhumanlinoleicacid/bloodlipids/bloodprotein-energymalnutrition/KWDblood/KWDcomplicationssupport,non-uKWDsKWDgov't
001030
A00A1133

Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .